Barriers to health care access and other socioeconomic factors may increase vulnerability in racial/ethnic minorities
Approval of Leqembi comes after controversial approval in 2021 of Aduhelm, which met with criticism over concerns about that drug's effectiveness, safety, pricing
Significant additive APOE ε4 interactions seen with PTSD and TBI in veterans of European ancestry
Controversy over Aduhelm stretches back to its June 2021 approval by the U.S. Food and Drug Administration
Individuals who were independently aware of the FDA decision demonstrated reduced willingness to participate
Moderately less decline seen in cognition and function at 18 months with lecanemab versus placebo
Authors say the health of family caregivers should be monitored in clinical practices
Association found for Alzheimer and Parkinson disease cases diagnosed before 60 years of age
Rural patients more likely to be diagnosed and treated by primary care providers
Rapid olfactory decline also associated with smaller gray matter volumes on MRI in olfactory- and memory-associated brain regions